Dermatological aspects of male hypogonadism

被引:0
|
作者
Köhn, FM
Ring, J
Schill, WB
机构
[1] Tech Univ Munich, Klin & Poliklin Dermatol & Allergol, D-80802 Munich, Germany
[2] Univ Giessen, Zentrum Dermatol & Androl, Giessen, Germany
来源
HAUTARZT | 2000年 / 51卷 / 04期
关键词
hypogonadism; androgens; testosterone; gonadotropins; skin lesions;
D O I
10.1007/s001050051025
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Since the skin and its appendages are androgen-dependent, male hypogonadism can be associated with dermatologically relevent lesions. The skin surface of hypogonadal patients is thin and shows increased wrinkles. In cases of prepubertal hypogonadism, severe acne does not occur. In contrast, patients may suffer from sebostasis due to missing stimulation of the sebaceous glands. The genital skin does not show pigmentation,which normaly develops during puberty; the integument is pale. Hair growth on breast, pubia, axilla, face and integument is reduced; patients do not present with typical androgenetic alopecia. In addition to these features, dermatological diseases caused by treatment of the hypogonadism or drug-induced skin reactions have to be considered. While drug reactions to oral or intramuscular androgens or gonadotropins are rare, irritative or allergic skin lesions are observed frequently, especially in cases of non-scrotal transdermal therapeutic systems with testosterone. A variety of syndromes include dermatological symptoms associated with male hypogonadism; however, the prevalence of these syndromes is low.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 50 条
  • [41] Hypogonadism in a male-to-female transsexual with super obesity
    Ayanian, S.
    Irwig, M. S.
    ANDROLOGIA, 2013, 45 (04) : 285 - 288
  • [42] Sperm Count and Hypogonadism as Markers of General Male Health
    Ferlin, Alberto
    Garolla, Andrea
    Ghezzi, Marco
    Selice, Riccardo
    Palego, Pierfrancesco
    Caretta, Nicola
    Di Mambro, Antonella
    Valente, Umberto
    Ponce, Maurizio De Rocco
    Dipresa, Savina
    Sartori, Leonardo
    Plebani, Mario
    Foresta, Carlo
    EUROPEAN UROLOGY FOCUS, 2021, 7 (01): : 205 - 213
  • [43] Bone benefits of testosterone replacement therapy in male hypogonadism
    Tirabassi, G.
    Biagioli, A.
    Balercia, G.
    PANMINERVA MEDICA, 2014, 56 (02) : 151 - 163
  • [44] Animal Models of Diabetes-Related Male Hypogonadism
    Dimakopoulou, Anastasia
    Jayasena, Channa N.
    Radia, Utsav K.
    Algefari, Metab
    Minhas, Suks
    Oliver, Nick
    Dhillo, Waljit S.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [45] The Roles of Aromatase Inhibitors in Treating Hypogonadism and Male Infertility
    Huang, William J.
    UROLOGICAL SCIENCE, 2022, 33 (03) : 114 - 118
  • [46] Male hypogonadotropic hypogonadism [Hypogonadotroper Hypogonadismus des Mannes]
    Köhn F.-M.
    MMW - Fortschritte der Medizin, 2023, 165 (Suppl 1) : 30 - 31
  • [47] Evaluation and Treatment of Male Hypogonadism
    Sargis, Robert M.
    Davis, Andrew M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 319 (13): : 1375 - +
  • [48] Male hypogonadism: Symptoms and treatment
    Kumar, Peeyush
    Kumar, Nitish
    Thakur, Devendra Singh
    Patidar, Ajay
    JOURNAL OF ADVANCED PHARMACEUTICAL TECHNOLOGY & RESEARCH, 2010, 1 (03) : 297 - 301
  • [49] Male hypogonadism and skeletal health
    Irwig, Michael S.
    CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY, 2013, 20 (06) : 517 - 522
  • [50] How to prescribe: Testosterone replacement therapy in male hypogonadism
    Lacarriere, E.
    PROGRES EN UROLOGIE, 2015, 25 (01): : F16 - F18